AmerisourceBergen Specialty Group – ABSG
For pharmaceutical manufacturers and healthcare providers, AmerisourceBergen Specialty Group is an essential business partner. We lead the market in biotechnology, plasma derivative and oncology product distribution. Pharmaceutical manufacturers rely on us for services like outsourced logistics and market access programs that support commercialization strategies. We provide the resources physicians need to maximize practice efficiency and the specialty pharmacy services patients need to improve their health.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Company Details
Latest Content from PMHub
Strategies to Launch and Commercialize Healthcare Innovations
Videos and Podcasts | December 10, 2020 | Impetus Digital
Dr. Roxie Mooney, Healthcare Commercialization Strategist at Legacy DNA and best-selling author, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital. We are discussing all things healthcare innovation and commercialization,...
Patient-Centered Digital Transformation
Videos and Podcasts | December 10, 2020 | Impetus Digital
Lygeia Ricciardi, Advisor at Carium, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital in this Fireside Chat. They explore a variety of topics related to patient-centric care, digital health transformation,...
Effects of the Pandemic on Evidence Generation & Scientific Exchange
Videos and Podcasts | December 10, 2020 | Impetus Digital
Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies and...
Press release: InSite Event™ named one of the most innovative services of 2020
Press Releases | December 10, 2020 | Impetus Digital
Press ReleaseContact: Jess Masciangelo, Business Development Directorjmasciangelo@impetusdigital.commeetwithimpetus.comINSITE EVENT™ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Event™...
Advance Outcomes named of the most innovative strategies of 2020 by PM360
Press Releases | December 10, 2020 | Lucid Group Communications Limited
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Lucid Group’s pioneering behaviour-change methodology, Advance OutcomesTM, as one of...
Lucid Group Evolve and Simplify its Brand Architecture
Press Releases | December 8, 2020 | Lucid Group Communications Limited
The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise...
University spin-out fund makes half a million pound first investments
Press Releases | December 8, 2020 | Onyx Health
University partnership Northern Accelerator has made over £500,000 worth of investments into two innovative university spin-out businesses in the health and biotech sectors from its £1.7M Seed Investment Fund
Migraine-friendly colours for the home
Press Releases | December 4, 2020 | 11 London
You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1,200 migraine...
The Future of Wearable and Implantable Devices
Videos and Podcasts | December 3, 2020 | Impetus Digital
Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....
Designing Ethical AI and Healthcare Technologies
Videos and Podcasts | December 3, 2020 | Impetus Digital
Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...